extend
frontier
genom
edit
enabl
radic
redesign
mammalian
genom
develop
set
base
editor
dbe
variant
allow
edit
ten
thousand
loci
per
cell
overcom
cell
death
associ
dna
doublestrand
break
dsb
singlestrand
break
ssb
use
set
grna
target
repetit
elementsrang
target
copi
number
per
cell
dbe
enabl
surviv
largescal
base
edit
allow
target
mutat
loci
human
induc
pluripot
stem
cell
hipsc
respect
three
order
magnitud
greater
previous
record
dbe
overcom
current
ontarget
mutat
toxic
barrier
prevent
cell
surviv
largescal
genom
engin
one
sentenc
summari
base
edit
reduc
dna
nick
allow
simultan
achiev
similar
effici
nativ
base
editor
gener
beyond
first
nbe
result
base
edit
broadli
demonstr
high
effici
rang
speci
includ
human
zygot
main
motiv
develop
be
avoid
dsb
reduc
level
random
vs
userspecifi
mutat
caus
live
sensit
cell
type
hipsc
howev
whether
be
enabl
concurr
edit
human
cell
site
numer
high
copi
te
explor
particularli
relev
genom
wide
recod
effort
genom
project
write
gpwrite
recod
human
genom
would
requir
estim
precis
modif
remov
instanc
one
three
stop
codon
assess
effici
toxic
current
edit
technolog
appli
te
design
test
grna
alu
herv
vari
copi
number
greater
across
genom
fig
alu
grna
respect
design
consensu
sequenc
obtain
repeatmask
tabl
consensu
fulllength
sequenc
encod
function
protein
final
grna
hervw
one
subfamili
herv
design
consensu
put
activ
retrovirus
tabl
perform
qpcr
genom
dna
gdna
gener
use
consensu
sequencebas
primer
estim
rel
abund
hek
ipsc
fig
copi
number
hervw
alu
element
edit
site
respect
estim
hek
ipsc
fig
te
copi
number
hek
higher
sinc
former
cell
larg
triploid
use
complementari
bioinformat
approach
second
estim
te
abund
align
design
grna
human
refer
genom
fig
fig
exampl
grna
target
shown
fig
total
number
match
allow
bp
mismatch
half
qpcr
estim
vast
major
intact
pam
fig
sinc
refer
sequenc
like
undercount
te
wellknown
problem
assembl
align
map
sequenc
base
edit
number
base
qpcr
copi
number
estim
high
copynumb
edit
induc
cellular
toxic
inhibit
surviv
edit
cell
transfect
hek
cell
plasmid
express
target
grna
disrupt
two
key
enzymat
domain
endonucleas
en
revers
transcriptas
rt
fig
tabl
three
day
transfect
observ
indel
frequenc
expect
target
rang
correspond
averag
respect
edit
per
haploid
genom
popul
fig
accord
previou
report
degre
genet
alter
toxic
confirm
increas
cell
death
apoptosi
propidium
iodid
annexin
v
stain
fig
followup
timecours
experi
provid
evid
cell
undergo
edit
hundr
loci
surviv
transfect
pair
grna
target
en
rt
enrt
domain
use
pair
grna
caus
larg
delet
bp
detect
gel
visual
fig
sampl
day
two
five
show
clear
edit
expect
delet
band
size
fig
longer
detect
day
indic
mutat
cell
either
die
suggest
previou
cell
death
assay
overgrown
wild
type
cell
deep
sequenc
expect
dual
grna
delet
band
confirm
grna
breakpoint
fig
visibl
band
day
repeat
experi
attempt
isol
clone
earli
indic
edit
clone
detect
mutat
day
beyond
data
shown
suggest
signific
level
indel
activ
toxic
limit
growth
clonal
isol
singl
cell
analysi
confirm
bimod
edit
frequenc
mean
delet
frequenc
fig
thought
nbe
could
help
improv
viabil
edit
cell
design
test
target
grna
tabl
gener
stop
codon
earli
use
deamin
transfect
hek
cell
grna
observ
level
deamin
target
locu
although
small
exceed
level
mock
transfect
control
cell
fig
cbe
grna
could
also
use
abe
contain
least
one
adenin
within
deamin
window
control
level
base
edit
observ
genom
dna
grna
ncbe
fig
nabe
fig
nabe
exhibit
highest
edit
effici
loci
three
day
transfect
use
go
forward
highest
signaltobackground
ratio
among
effici
grna
target
window
also
contain
three
efficientlycoedit
c
thu
offer
clear
signal
direct
mutat
anoth
experi
alu
target
grna
show
increas
cell
surviv
use
compar
fig
suggest
nbe
may
reduc
toxic
target
high
copi
number
sequenc
transfect
either
control
sampl
receiv
nontarget
grna
two
day
posttransfect
singl
cell
display
deamin
estim
loci
fig
highest
edit
singl
cell
significantli
higher
mean
deamin
frequenc
earli
timepoint
could
form
stabl
clonal
popul
day
timepoint
suggest
increas
overal
cell
viabil
target
high
copi
repeat
four
surviv
cell
line
isol
deamin
frequenc
estim
site
fig
data
present
fig
show
puriti
desir
deamin
product
edit
window
clone
k
highest
edit
stabl
clonal
popul
target
mutat
frequenc
day
confirm
subject
top
edit
singl
cell
isol
clone
k
anoth
round
edit
fig
detect
cell
nucleotid
convers
day
four
live
clone
isol
mutat
frequenc
rang
correspond
edit
fig
clone
highest
number
deamin
site
grow
freez
thaw
cycl
three
cell
line
stabl
cultur
period
longer
day
term
clone
clone
clone
respect
edit
respect
observ
highest
edit
clone
die
initi
detect
observ
type
editor
confirm
nbe
activ
lower
copi
number
target
hervw
averag
nucleotid
convers
popul
level
fig
due
difficulti
amplifi
analyz
alu
target
like
high
subfamili
polymorph
short
repeat
sequenc
proceed
exclus
target
grna
rest
confirm
edit
genom
level
reflect
correspond
transcript
perform
rnaseq
clone
k
clone
clone
analyz
percentag
convers
result
stop
codon
rna
read
fig
theoret
sinc
activ
subset
gener
transcript
presenc
expect
stop
codon
messeng
rna
level
may
indic
inactiv
result
show
higher
number
edit
clone
correl
higher
number
stop
codon
rna
level
suggest
transcript
activ
subfamili
impact
multiplex
edit
nickless
dbe
enabl
isol
stabl
cell
line
harbor
edit
suspect
gener
singlestrand
nick
genomewid
could
lead
cytotox
decid
inactiv
remain
hnh
nucleas
domain
mutat
backbon
creat
set
includ
dabe
nickless
test
singl
locu
target
confirm
deamin
activ
compar
nbe
equival
exist
show
improv
edit
effici
day
five
respect
fig
compar
nick
counterpart
reduct
effici
indel
activ
reduc
background
level
fig
dabe
retain
nabe
effici
singl
locu
target
reduc
indel
level
background
fig
transfect
cell
either
nabe
dabe
individu
sort
analyz
cell
target
nucleotid
convers
day
singl
edit
cell
result
edit
effici
loci
observ
signific
reduct
mean
target
nucleotid
mutat
frequenc
dcbe
dabe
compar
nbe
equival
fig
parallel
singl
cell
grown
determin
whether
viabl
highli
edit
clone
could
isol
edit
effici
trend
revers
live
cell
dbe
show
significantli
increas
deamin
frequenc
nbe
fig
remark
dabe
produc
highest
edit
viabl
clone
target
nucleotid
convers
estim
loci
estim
highest
edit
clone
inactiv
loci
sequenc
base
editor
retain
nick
activ
gener
rare
cell
edit
frequenc
consist
prior
experi
fig
result
replic
use
anoth
target
grna
similar
trend
observ
fig
nucleotid
composit
base
grna
pam
display
highest
edit
clone
parent
control
condit
use
show
low
nonspecif
nucleotid
convers
nbe
dbe
fig
mean
singl
cell
mutat
frequenc
reduc
use
nabe
use
dabe
indic
disabl
nick
result
decreas
edit
effici
day
timepoint
fig
fourteen
day
transfect
dbe
gain
mark
advantag
compar
nbe
total
number
viabl
cell
mutat
frequenc
singl
cell
increas
mean
edit
frequenc
among
surviv
live
clone
use
dabe
compar
nabe
fig
increas
observ
compar
high
base
edit
puriti
observ
abe
cbe
gener
nonintend
base
target
posit
dcbe
significantli
reduc
gener
nonintend
base
convers
detect
target
fig
first
three
day
edit
dbe
lower
edit
frequenc
compar
nbe
day
seven
dabe
gain
signific
edg
nabe
fig
chromosom
integr
analysi
perform
clone
edit
nabe
dabe
karyotyp
result
shown
tabl
show
top
edit
clone
significantli
differ
control
group
term
total
number
aberr
fig
analysi
karyotyp
normal
stabl
cell
line
requir
fulli
assess
chromosom
stabil
largescal
genom
edit
dabe
allow
isol
hipsc
harbor
edit
next
attempt
largescal
genom
edit
hipsc
surviv
cocktail
singl
cell
isol
time
line
shown
fig
experi
conduct
two
slight
variat
electropor
protocol
term
total
cell
transfect
total
amount
dna
use
cs
pk
condit
singl
cell
sort
analyz
target
nucleotid
convers
frequenc
hour
post
electropor
highest
edit
singl
cell
target
convers
site
fig
parallel
live
singl
cell
isol
stabl
cell
line
form
day
post
transfect
coloni
analyz
target
nucleotid
convers
mean
edit
frequenc
cs
pk
condit
respect
hour
transfect
fig
day
median
edit
effici
cs
live
clone
higher
pk
live
clone
contrast
valu
observ
earlier
time
point
suggest
lower
initi
edit
effici
may
increas
viabil
stabli
edit
cell
line
highest
edit
clone
nucleotid
convers
frequenc
correspond
site
genom
wide
exceed
three
order
magnitud
number
simultan
edit
previous
record
ipsc
increas
background
occur
singl
cell
direct
analysi
fig
compar
isol
expand
coloni
fig
like
due
necessari
overamplif
requir
get
enough
genom
materi
singl
cell
similar
observ
made
previou
experi
use
cell
previous
test
dna
editor
fail
produc
detect
edit
locu
human
ipsc
sensit
even
minor
dna
damag
rapidli
deplet
cell
transfect
te
grna
time
fig
crispr
recent
brought
radic
transform
basic
appli
biolog
research
lead
commerci
applic
multitud
clinic
trial
even
controversi
test
human
germlin
modif
use
crispr
myriad
deriv
greatli
reduc
activ
energi
technic
skill
requir
perform
genom
edit
sever
barrier
limit
fundament
clinic
applic
need
custom
grna
target
difficult
deliveri
ineffici
deliv
target
error
ontarget
error
cytotox
dna
damag
multiplex
beyond
loci
limit
insert
size
immun
reaction
ca
grna
vector
studi
aim
develop
tool
address
weak
improv
actual
multiplex
eukaryot
genom
edit
capabl
sever
order
magnitud
hold
potenti
revolution
human
healthcar
combinatori
function
biolog
popul
genet
human
diseas
patholog
multiplex
edit
also
permit
develop
success
engin
cell
treatment
chimer
antigen
receptor
car
therapi
requir
simultan
edit
three
target
gene
futur
treatment
may
requir
mani
modif
augment
cancer
immunotherapi
slow
oncogen
growth
reduc
advers
effect
hostversusgraft
diseas
furthermor
custom
hostversusgraft
antigen
humanor
nonhumandonor
tissu
may
requir
modif
made
far
develop
genomewid
edit
technolog
need
special
attent
paid
safeti
edit
impact
function
activ
transplant
sinc
donor
tissu
may
persist
patient
decad
complet
genomewid
recod
enabl
project
gpwrite
ultrasaf
cell
deextinct
effort
regain
lost
biodivers
safe
dna
editor
must
develop
increas
number
genet
modif
possibl
sever
order
magnitud
without
trigger
overwhelm
dna
damag
well
overcom
deliveri
multipl
distinct
grna
per
cell
latter
address
studi
massiv
modifi
strain
e
coli
instanc
amber
stop
codon
replac
attempt
feat
human
genom
requir
modif
amber
codon
shown
gene
editor
caus
doubleor
singlestrand
dna
break
gener
number
edit
suffici
theoret
achiev
genom
recod
pave
way
toward
make
panviru
resist
human
cell
could
commerci
applic
toward
cellbas
product
monoclon
antibodi
recombin
protein
therapeut
synthet
meat
product
studi
demonstr
genomewid
disrupt
high
copi
number
repetit
element
possibl
open
new
opportun
studi
dark
matter
genom
cbe
allow
gener
stop
codon
within
open
read
frame
great
tool
probe
function
transpos
element
potenti
turn
observ
associ
physiopatholog
phenotyp
causat
instanc
largescal
inactiv
hervw
element
could
help
investig
respect
role
multipl
sclerosi
neurolog
process
indepth
studi
necessari
howev
assess
impact
massiv
edit
normal
cell
process
sinc
collater
damag
may
occur
expect
thorough
offtarget
analysi
repetit
element
remain
difficult
task
accomplish
due
high
level
polymorph
therefor
strong
biolog
control
well
new
experiment
bioinformat
pipelin
need
overcom
challeng
studi
observ
dabe
increas
viabil
highli
edit
clone
compar
dcbe
differ
may
explain
two
factor
first
use
cbe
three
target
nucleotid
within
deamin
window
compar
one
abe
consequ
cbe
convert
three
time
nucleotid
abe
potenti
caus
addit
cytotox
second
use
cbe
uracil
nglycosylas
activ
catalyz
remov
deamin
cytosin
gener
sever
nick
genomewid
promot
dna
damag
potenti
cell
death
convers
adenosin
inosin
use
abe
may
detect
effici
dna
repair
machineri
therefor
increas
viabil
largescal
edit
random
genomewid
offtarget
snv
report
cbe
appear
independ
grna
bind
site
thu
anticip
condit
modul
dna
repair
process
mismatch
repair
base
excis
repair
trigger
downstream
singleand
doublestrand
break
genom
improv
extent
dbe
final
sinc
dbe
gener
direct
break
genom
decreas
indel
frequenc
background
may
trigger
dna
sensor
retain
target
nucleotid
convers
frequenc
compar
nbe
counterpart
consequ
success
genet
modif
dbe
may
enrich
prooncogen
cell
disrupt
dnadamag
guardian
report
even
low
level
multiplex
featur
may
promot
dbe
essenti
tool
therapeut
applic
gene
therapi
summari
work
optim
largescal
genom
edit
enabl
cell
viabil
simultan
edit
thousand
loci
per
singl
cell
abil
safe
edit
mani
loci
genom
wide
may
facilit
true
potenti
person
medicin
develop
understand
gene
interact
epistasi
envis
new
safe
dna
editor
combin
improv
multiplex
deliveri
grna
usher
new
phase
synthet
biolog
possibl
imagin
recod
whole
mammalian
genom
combin
modul
dna
repair
prosurviv
factor
may
limit
number
base
modifi
singl
genom
open
new
avenu
previous
thought
possibl
overcom
toxic
limit
prevent
largescal
genom
edit
human
ipsc
expand
edit
boundari
three
order
magnitud
continu
develop
multiplex
deliveri
along
nontox
higheffici
dna
editor
without
dsb
ssb
paramount
success
genomewid
recod
effort
probe
inner
work
life
ultim
lead
radic
redesign
figur
tabl
supplementari
result
supplementari
refer
ccbyncnd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
b
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
c
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
